Abstract
The causes for the highly selective loss of dopaminergic neurons in the substantia nigra pars compacta in Parkinson’s disease (PD) are still unknown. However, a major advance has been recently made with the introduction of the concept of apoptosis as the route leading this specific neuronal population to degeneration. Apoptosis, or programmed cell death (PCD), is an active, controlled program inherent in every living cell. Upon receiving certain signals, cells that are destined to die undergo a highly characteristic process of “suicide.” This process consists of massive biochemical and morphological alterations, including cell shrinkage, loss of cell-to-cell contacts, blebbing of cell membranes, cytoskeletal rearrangements, and DNA condensation and fragmentation. It culminates in cell conversion to membrane-bound particles (apoptotic bodies) that are ready to be digested by neighboring macrophages (1–3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462.
Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445–1449.
Searle, J, Kerr, J. F., and Bishop, C. J. (1982) Necrosis and apoptosis, distinct modes of cell death with fundamentally different significance. Ann. Pathol. 17, 229–259.
Burek, M. J. and Oppenheim, R. W. (1996) Programmed cell death in the developing nervous system. Brain Pathol. 6, 427–446.
Bredesen, D. E. (1995) Neural apoptosis. Ann. Neurol. 38, 839–851.
Hayes, T. E., Valtz, N. L. M., and McKay R. D. G. (1991) Downregulation of CDC2 upon terminal differentiation of neurons. New Biol. 3. 259–269.
Cotman, C. W. and Anderson, A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer’s disease. Cell. Mol. Neurobiol. 10, 19–45.
Ziv, I. and Melamed, E. (1998) Role of apoptosis in the pathogenesis of Parkinson’s disease; a novel therapeutic opportunity? Mov. Disord. 13, 865–870.
Ma, S. Y., Rinne, J. O., Collan, Y., Royata, M., and Rinne, U. K. (1996) A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson’s disease. J. Neurol. Sci. 140, 40–45.
Mochizuki, H., Mori, H., and Mizuno, Y. (1997) Apoptosis in neuro-degenerative disorders. J. Neural Transm. 50, 125–140.
Anglade, P., Vyas, S., and Javoy-Agid, F. (1995) Apoptotic degeneration of nigral dopaminergic neurons in Parkinson’s disease. Soc. Neurosci. Abst. 21, 1250.
Johnson, G. (1971) Quatitation of fluorescence of biogenic monoamines. Prog. Hystochem. Cytochem. 2, 299–344.
Michel, P. P. and Hefti, F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428–435.
Wick, M. M. (1978) Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J. Invest. Dermatol. 71, 163,164.
Wick, M. M. (1989) Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. J. Invest. Dermatol. 92, 329S–331S.
Eastman, A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2, 275–280.
Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., and Barzilai, A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons-a possible novel pathogenetic mechanism in Parkinson’s disease. Neurosci. Lett. 170, 136–140.
Ziv, I., Barzilai, A., Offen, D., Nardi, N., and Melamed, E. (1997) Nigrostiatal neuronal death in Parkinson’s disease-a passive or an active genetically-controlled process? J. Neural. Transm. 49, 69–76.
Offen, D., Ziv, I., Gordin, S., Barzilai, A., Malik, Z., and Melamed, E. (1995) Dopamine-induced programmed-cell-death in mouse thymocytes. Biochim. Biophys. Acta 1268, 171–177.
Zilkha-Falb, R., Ziv, I., Nardi, N., Offen, D., Melamed, E., and Barzilai, A. (1997) Monoamine-induced apoptotic neuronal cell death. Cell. Mol. Neurobiol. 17, 101–118.
Ziv, I., Zilkha-Falb, R., Offen, D., Shirvan, A., Barzilai, A., and Melamed, E. (1997) Levodopa induces apoptosis in cultured neuronal cells-a possible accelerator of nigrostriatal degeneration in Parkinson’s disease? Mov. Disord. 12, 17–23.
Offen, D., Ziv, I., Barzilai, A., Gordin, S., Glater, E., Hochman, A., and Melamed, E. (1997) Dopamine-melanin induces apoptosis in PC12 cells: possible implications for the etiology of Parkinson’s disease. Neurochem. Int. 31, 207–216.
Offen, D., Ziv, I., Sternin, H., Melamed, E., and Hochman, A. (1996) Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson’s disease. Exp. Neurol. 141, 32–39.
Payne, C. M., Bernstein, C., and Bernstein, H. (1995) Apoptosis overview, empahsizing the role of oxidative stress, DNA damage and signal transduction pathways. Leuk. Lymph. 19, 43–93.
Moldeus, P., Nordenskjold, M., and Bolcsfoldi, G. (1983) Genetic toxicity of dopamine. Mut. Res. 124, 9–23.
Yonich-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., and Oren, M. (1993) p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13, 1415–1423.
Daily, D., Barzilai, A., Offen, D., Melamed, E., and Ziv, I. (1999) The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells over-expressing p53. Cell. Mol. Neurobiol. 2, 261–276.
Shirvan, A., Ziv, I., Machlin, T., Zilkha-Falb, R., Melamed, E., and Barzilai, A. (1997) Two waves of cyclin B and proliferating cell nuclear antigen expression during dopamine-triggered neuronal apoptosis. J. Neurochem. 69, 539–549.
Shirvan, A., Ziv, I., Fleminger, G., Machlin, T., Brudo, I., Melamed, E., and Barzilai, A. (1999) Semaphorins as mediators of neuronal apoptosis. J. Neurochem. 73, 961–971.
Luo, Y., Umegaki, H., Wang X., Abe, R., and Roth, G. S. (1998). Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem. 273, 3756–3764.
Reed, J. C. (1997) Double identity for proteins of the Bcl-2 family. Nature 387, 773–776.
Offen, D., Ziv, I., Panet, H., Wasserman, L., Stein, R., Melamed, E., and Barzilai, A. (1997) Dopamine-induced apoptosis is inhibited in PC-12 cells expressing Bcl-2. Cell. Mol. Neurobiol. 17, 289–304.
Hochman, A., Sternin, H., Gorodin, S., Korsmeyer, S., Ziv, I., Melamed, E., and Offen, D. (1998) Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J. Neurochem. 71, 741–748.
Liang P. and Pardee A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.
Bauer D., Muller H., Reich J., Riedel H., Ahrenkiel V., Warthop I., and Strauss M. (1993) Identification of differentially expressed mRNA species by improved display technique (DDRT-PCR). Nucleic Acid Res. 21, 4272–4280.
Greene L. A. (1977) Quantitative in vitro studies on the nerve growth factor (NGF) requirements for neurons. 1. Sympathetic neurons. Dev. Biol. 58, 96–105.
Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Ziv, I., Shirvan, A., Offen, D., Barzilai, A., Melamed, E. (2001). Molecular Biology of Dopamine-Induced Apoptosis. In: Maral Mouradian, M. (eds) Parkinson's Disease. Methods in Molecular Medicine™, vol 62. Humana Press. https://doi.org/10.1385/1-59259-142-6:73
Download citation
DOI: https://doi.org/10.1385/1-59259-142-6:73
Publisher Name: Humana Press
Print ISBN: 978-0-89603-761-8
Online ISBN: 978-1-59259-142-8
eBook Packages: Springer Protocols